SCHEMBL19428601

SCHEMBL19428601

COC(=O)CC(F)(F)CC(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.42
HSD17B10 Q99714 2/20 0.42
HMGCR P04035 1/20 0.37
CHRM1 P11229 1/20 0.37
TBXA2R P21731 1/20 0.37
ADRA1A P35348 1/20 0.37
MGAM O43451 1/20 0.37
GAA P10253 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
ACLY P53396 2/20 0.35
TET2 Q6N021 1/20 0.35
RECQL P46063 2/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HPGD P15428 1/20 0.33
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18530351 0.91 TSHR (0.48) TSHRHSD17B10MGAMGAASI
SCHEMBL25772273 0.80 ACLY (0.48) TSHRHMGCRCHRM1TBXA2RADRA1A
SCHEMBL18591938 0.79 TSHR (0.42) TSHRHSD17B10MGAMGAASI
SCHEMBL18598224 0.78 GAA (0.44) TSHRHSD17B10HMGCRCHRM1TBXA2R
SCHEMBL2390553 0.75
Methyl Carbamate SCHEMBL29833641 0.75 TSHR (0.36) TSHRHSD17B10HMGCRCHRM1TBXA2R
SCHEMBL162441 0.74 KDM4E (0.48) TSHRHSD17B10HMGCRCHRM1TBXA2R
SCHEMBL2856954 0.74 ALDH1A1 (0.62) TSHRHSD17B10HMGCRCHRM1TBXA2R
SCHEMBL27800877 0.74 ALDH1A1 (0.62) TSHRHSD17B10HMGCRCHRM1TBXA2R
SCHEMBL27009184 0.74 TSHR (0.37) TSHRHSD17B10MGAMGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240016946-A1 DRUG-LOADED MACROMOLECULE AND PREPARATION METHOD THEREFOR SHANGHAI SHENGDI PHARMACEUTICAL CO., LTD. (CN) 2024-01-18 US disclosed
US-11656548-B2 Actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, mask blank with resist film, method for producing photomask, and method for manufacturing electronic device FUJIFILM CORPORATION (JP) 2023-05-23 US disclosed
US-20170285469-A1 RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN TOKYO OHKA KOGYO, CO., LTD. (JP) 2017-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240016946-A1 DRUG-LOADED MACROMOLECULE AND PREPARATION METHOD THEREFOR MRPL38, MRPS27, MRPS18A TSHR 4314/4885HSD17B10 3027/4885HMGCR 1384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.